SIREN : 438407116
ISOCELL is a French company founded 24 years ago, specialized in the sector Activités des sociétés holding. Based in PARIS (75015), this company of category PME shows in 2024 a revenue of 389 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 388 795 € | 349 705 € | 362 873 € | 359 364 € | 351 289 € | 349 243 € | 360 773 € | 254 731 € | 244 876 € |
| Net income | 149 925 € | 149 507 € | 63 009 € | 73 572 € | 72 938 € | -5 196 296 € | 189 851 € | 96 883 € | 496 217 € |
| EBITDA | 102 728 € | 93 889 € | 70 014 € | 87 431 € | 88 812 € | 49 206 € | 114 027 € | 73 149 € | 53 458 € |
| Net margin | 38.6% | 42.8% | 17.4% | 20.5% | 20.8% | -1487.9% | 52.6% | 38.0% | 202.6% |
In 2024, ISOCELL achieves revenue of 389 k€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +5.9%. Vs 2023, growth of +11% (350 k€ -> 389 k€). After deducting consumption (0 €), gross margin stands at 389 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 103 k€, representing 26.4% of revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 150 k€, i.e. 38.6% of revenue. This profit can be retained or distributed to shareholders.
388 795 €
388 795 €
102 728 €
50 458 €
149 925 €
26.4%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 95%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Cash flow represents 39.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
0.0%
94.682%
39.242%
0.0
3.9%
In 2024, the debt ratio of ISOCELL (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of ISOCELL (94.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2024, the repayment capacity of ISOCELL (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 1581.69. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
1581.693
0.0
In 2024, the liquidity ratio of ISOCELL (1581.69) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of ISOCELL (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 39 days. Excellent situation: suppliers finance 39 days of the operating cycle (retail model). Overall, WCR represents 1504 days of revenue, i.e. 1.6 M€ to permanently finance. Notable WCR improvement over the period (-68%), freeing up cash.
1 624 763 €
0 j
39 j
0 j
1504 j
Based on 54 transactions of similar company sales
in 2024,
the value of ISOCELL is estimated at
360 839 €
(range 112 689€ - 733 627€).
With an EBITDA of 102 728€, the sector multiple of 4.8x is applied.
The price/revenue ratio is 0.59x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare ISOCELL with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of ISOCELL in 2024 is 389 k€.
Yes, ISOCELL generated a net profit of 150 k€ in 2024.
The headquarters of ISOCELL is located in PARIS (75015), in the department Paris.
The tax return of ISOCELL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
ISOCELL operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.